GUANGZHOU, China, May 12, 2026 /PRNewswire/ -- TCL CSOT, a global leader in advanced display technologies and a subsidiary of TCL Technology, held a topping-out ceremony for its Gen 8.6 Inkjet-printed OLED (IJP OLED) production line in Guangzhou, China, known as the t8 project. With the completion of the main factory structure and the cleaning work, the world's first Gen 8.6 IJP OLED production line has entered its next critical phase of development.

Key Milestone Reached: Project Enters New Stage

As a strategic initiative, the t8 project drives TCL CSOT's next-gen display layout and IJP OLED industrial scaling. With a total investment of US$4.34 billion (RMB 29.5 billion)^[1] and a monthly capacity of 22,500 glass substrates, the project achieved remarkable efficiency. Following its groundbreaking on Nov. 30, 2025, the main structure was completed in just 151 days—setting an industry record for the fastest topping-out and epitomizing TCL CSOT's efficiency.

Dr. Weiran Cao, Chief of the IJP OLED Center at TCL CSOT, said, "Our early completion honors our team's dedication. As the world's first mass-production Gen 8.6 IJP OLED line, t8 secures our leadership in the next-gen display industry."

Following the topping-out, the project will enter the comprehensive stages of finish work, power-system installation, and core-equipment relocation.  

Deepening Technological Accumulation: A New Engine for Industrial Upgrading

With 13 years of R&D experience in IJP OLED technology, TCL CSOT has built a full end-to-end production system. The Wuhan G5.5 IJP OLED line in China, known as t12, achieved mass production and product delivery in November 2024, providing mature experience and optimized yields necessary to drive the t8 project forward efficiently.

As the world's first mass-production Gen 8.6 IJP OLED line, the t8 project utilizes inkjet-printing processes to precisely deposit organic light-emitting materials onto 2290×2620mm Gen 8.6 glass substrates via "on-demand deposition." Compared to traditional vacuum evaporation, IJP OLED offers superior material utilization, higher yields, and eco-friendly production. Targeting the high-end mid-size display market—including mobile, desktop, TV and automotive displays—this project bolsters premium supply and marks TCL CSOT's transition from pilot R&D to advanced manufacturing.

Looking ahead, with the completion and activation of the t8 project, TCL CSOT will gradually build an OLED product portfolio covering multiple sizes and scenarios. By leveraging cutting-edge technologies and premium products, TCL CSOT aims to deliver the ultimate display experience to global users.

Group Revenue Up 6.4% YoY In A Challenging Environment;
CYBEX Delivers Strong 12.9% Growth, Significantly Gaining Market Shares

HONG KONG, May 12, 2026 /PRNewswire/ -- Goodbaby International Holdings Limited ("Goodbaby International" or the "Company"; HKEX stock code: 1086, together with its subsidiaries, the "Group"), a global leading juvenile products brand house, has announced its unaudited revenue performance for the three months ended 31 March 2026 (the "Period").

Key Revenue Highlights

• Group revenue: HK$2,166.0 million, an increase of 6.4% from HK$2,034.9 million in the same period of 2025, continuing to consolidate its global leading position;
• CYBEX: revenue HK$1,293.1 million, an increase of 12.9% based on strong business momentum, continuing to gain market shares across markets and categories;
• Evenflo: revenue growth of 3.1%, supported by very strong growth in strollers and home goods;
• gb: slight revenue decrease amid ongoing brand transformation focusing on core durables categories, with strong growth recorded in car seats;
• Blue Chip: revenue declined against a high comparable base in the same period of 2025 resulting from front-loaded orders from customers.

Brand Performance Review

CYBEX 
Achieved robust double-digit growth on a high base in a challenging environment, reinforcing its position as the global leading premium "technical – lifestyle" brand. CYBEX continued to significantly gain market shares across markets and categories, supported by strong business momentum;

Evenflo 
Recorded revenue growth, mainly driven by very strong performance in strollers and home goods. Evenflo consolidated its leading position in the North American market as it stabilizes its business;

gb 
Recorded a slight revenue decrease in line with business focus on core durables categories under business transformation; gb remained a top-tier consumer brand with strong recognition in the China market;

Blue Chip 
Revenue declined from a high base in the same period of 2025 resulting from front-loaded orders. The Group continued to deliver efficient, high-quality and timely services to its Blue Chip customers.

Management Comment

Mr. Tongyou LIU, Executive Director and Group CEO of Goodbaby International, stated:

"Against a complex and uncertain macro environment, the Group delivered solid revenue performance in the first quarter, further consolidating our global leading position. We expect challenges to persist in the remainder of 2026, such as inflation, raw material cost increases, unfavorable foreign exchange fluctuations, negative consumer sentiment and logistics disruptions, caused by intensified geopolitical tensions. We will stay focused on our long-term strategy of globalization and operations of own brand portfolio, execute planned agenda prudently and leverage the advantages of our integrated platform that combines diversified manufacturing and operational services to support sustainable long-term growth."

About Goodbaby International Holdings Limited 
Goodbaby International Holdings Ltd. (stock code: 1086) is a world-leading juvenile products brand house. The Group serves millions of families around the world under own brand names through design, research and development, manufacture, marketing and sales of children's car safety seats, wheeled goods, apparel and home textile products, feeding, nursing and personal care products, cribs, ride-ons and other juvenile products.

For more information, please visit Goodbaby's corporate website: www.gbinternational.com.hk. 

SHENZHEN, China, May 12, 2026 /PRNewswire/ -- Tencent Music Entertainment Group ("TME," or the "Company") (NYSE: TME and HKEX: 1698), the leading online music and audio entertainment platform in China, today announced its unaudited financial results for the first quarter ended March 31, 2026.

First Quarter 2026 Financial Highlights

• Total revenues were RMB7.90 billion (US$1.15 billion), representing a 7.3% year-over-year increase, primarily due to strong growth in revenues from music related services^[1].
• Revenues from music related services^[1] were RMB6.51 billion (US$944 million), representing 12.2% year-over-year growth. Revenues from membership services^[2] were RMB4.57 billion (US$662 million), representing 6.6% year-over-year growth. Revenues from music related services other than membership services were RMB1.94 billion (US$282 million), representing 28.0% year-over-year growth.
• On an IFRS basis:
  • Net profit attributable to equity holders of the Company was RMB2.09 billion (US$303 million), compared with RMB4.29 billion in the same period of 2025, as the Company has recognized a gain of RMB2.37 billion on deemed disposal of an associate in the first quarter of 2025.
  • Diluted earnings per ADS was RMB1.34 (US$0.19), compared with RMB2.77 in the same period of 2025.
• On a non-IFRS basis:
  • Adjusted EBITDA^[3] was RMB2.83 billion (US$410 million), representing 10.5% year-over-year growth.
  • Non-IFRS net profit attributable to equity holders of the Company^[3] was RMB2.27 billion (US$330 million), representing 7.0% year-over-year growth.
  • Non-IFRS diluted earnings per ADS was RMB1.46 (US$0.21), up from RMB1.37 in the same period of 2025.
• Total cash, cash equivalents, term deposits and short-term investments as of March 31, 2026 were RMB41.00 billion (US$5.94 billion).

Mr. Cussion Pang, Executive Chairman of TME, commented, "This quarter's steady results reflect the effectiveness of our holistic approach to the music ecosystem. By expanding how we serve and engage our audience, we have built a more diversified and resilient model, supported by continued strong growth beyond membership services in our music related business. While AI is broadening participation in content creation, it does not replace human creativity and, in many ways, reinforces the scarcity and intrinsic value of premium IP—which remains central to deeper engagement and greater wallet share. Rooted in strong copyright protection, we are committed to channeling this value to elevate the creative economy, unlock new opportunities across the music industry, and drive enduring long-term value."

Mr. Ross Liang, CEO of TME, continued, "As we operate in an increasingly competitive landscape, we remain focused on strengthening the resilience of our platform. Anchored by our content-and-platform dual engine, we continue to bolster differentiation, drive engagement, and expand user lifetime value. Leveraging Tencent's ecosystem, we are broadening user reach and deepening penetration, while advancing a tiered subscription strategy to better address diverse user needs. During the quarter, we delivered continued improvement in SVIP adoption and user engagement. Together, these initiatives position us to compete effectively while driving scalable growth and durable monetization over time."

First Quarter 2026 Operational Highlights

CONTENT – To unlock long-term value, we continued to invest in premium IP to drive differentiation and engagement, while leveraging AI to enrich content creation and improve efficiency.

• Strengthened our premium evergreen catalog by renewing key label partnerships, including JVR Music, Linfair Records, and MOK-A-BYE BABY MUSIC LTD., securing access to iconic artists such as Jay Chou, Karen Mok, Harlem Yu, and Angela Zhang^[4]. We also deepened our strategic partnership with TF Entertainment through 30-day early release windows and expanded physical collaboration, reinforcing our content leadership and competitive differentiation.
• Captured more user mindshare with our proprietary content. High-impact releases—including Zhou Shen's chart-topping theme song for Sony Pictures' Project Hail Mary—collectively drove incremental streams across our self-produced catalog and further enhanced its visibility.
• Harnessed AI to enhance production efficiency and revitalize classic IP. Our AI tools empower creators by lowering production barriers and accelerating workflows, effectively increasing content supply, with AI-generated songs accounting for a growing share of daily new releases. High-quality, authorized AI covers reintroduce classic works to new audiences and drive incremental engagement with original tracks.

PLATFORM – Sustained our user base through a multi-pronged approach and advanced a multi-tiered monetization strategy, including new offerings to capture demand for super-premium music experiences.

• Recently stepped up collaboration with the Tencent's Weixin Video Account to create a seamless funnel that converts casual background music (BGM) discovery into high-quality music streaming, enabling us to strengthen user base and drive incremental traffic.
• To better engage casual listeners, we diversified touchpoints across the platform. Combined with AI-driven recommendations with interactive features, these initiatives encourage users to favorite tracks and curate playlists, fostering the accumulation of personal music assets.
• SVIP membership continued to see solid adoption and engagement. To enhance its appeal, we appointed major artists such as Ryan Ding, Ju Jingyi, Liu Yuning, JC-T, and Karry Wang as ambassadors for a variety of collaborations. We also introduced tailored collections for leading K-pop artists such as BLACKPINK, EXO, and IVE, combining digital albums with physical collectibles including NFC cards.
• To meet demand for super-premium experiences, we launched our inaugural Fan Club membership with Silence Wang, integrating priority ticketing and exclusive merchandise to further enrich the fan experience.

IP-VALUE – Adopted a holistic, pan-IP approach to amplify music influence, simultaneously boosting user reach, engagement, and wallet share.

• Extended the IP value chain and unlocked commercial value through innovative virtual and physical offerings. A prime example is our strengthened partnership with Jay Chou for his digital album, Children of the Sun where combined digital and physical benefits drove strong engagement and generated over RMB100 million in sales.
• Achieved triple-digit year-over-year growth in revenues related to live performance while growing our IP's global footprint. We hosted flagship concerts with leading K-pop groups, including BABYMONSTER's concerts in Taiwan, China, and NCT WISH's concerts in Hong Kong, China, and elevated strategic artists such as Will Pan, Silence Wang, Tia Ray, Angela Zhang, Jane Zhang, Zhang Yuan, and GAI onto prominent domestic and international stages, enhancing their global reach and commercial value.

First Quarter 2026 Financial Review

Total revenues increased by RMB539 million, or 7.3%, to RMB7.90 billion (US$1.15 billion) from RMB7.36 billion in the same period of 2025.

• Revenues from music related services increased by 12.2% to RMB6.51 billion (US$944 million), compared with RMB5.80 billion in the same period of 2025. The increase was driven by solid growth in revenues from membership services and offline performances related services, supplemented by growth in revenues from advertising services. Revenues from membership services were RMB4.57 billion (US$662 million), representing 6.6% year-over-year growth, compared with RMB4.28 billion in the same period of 2025. The growth was mainly driven by our continuous expansion of SVIP membership privileges, such as early access to offline performances and artist-related merchandise, and the launch of other new membership programs, such as bubble, WeverseDM, and fan-club membership. Revenues from offline performances related services achieved robust year-over-year growth. We successfully staged several successful concerts for our strategically collaborated local and Korean artists across domestic and overseas markets. The year-over-year increase in revenues from advertising services was primarily due to our more diversified product portfolio and innovative ad formats, such as ad-supported mode.
• Revenues from social entertainment services and others decreased by 11.0% to RMB1.38 billion (US$200 million) from RMB1.55 billion in the same period of 2025.

Cost of revenues increased by 5.7% year-over-year to RMB4.35 billion (US$630 million), mainly due to increased costs related to offline performances, advertising services and other IP related services. Meanwhile, revenue sharing fees decreased, resulting from declines in both revenue sharing ratio and revenues from social entertainment services. 

Gross margin increased to 44.9% from 44.1% in the same period of 2025, primarily due to increase in revenues from membership services, along with decreased channel fee.

Total operating expenses increased by 5.9% year-over-year to RMB1.21 billion (US$176 million). Operating expenses as a percentage of total revenues decreased to 15.3% from 15.5% in the same period of 2025. 

• Selling and marketing expenses were RMB271 million (US$39 million), representing a 36.2% year-over-year increase. The increase was primarily due to higher channel spending and content promotion expenses.
• General and administrative expenses were RMB940 million (US$136 million), and remained relatively stable compared with the same period of 2025.

On an IFRS basis, net profit and net profit attributable to equity holders of the Company for the first quarter of 2026 were RMB2.14 billion (US$310 million) and RMB2.09 billion (US$303 million), respectively. Basic and diluted earnings per American Depositary Shares ("ADS") for the first quarter of 2026 were RMB1.36 (US$0.20) and RMB1.34 (US$0.19), respectively. The Company had weighted averages of 1.54 billion basic and 1.56 billion diluted ADSs outstanding, respectively. Each ADS represents two of the Company's Class A ordinary shares.

On a non-IFRS basis, adjusted EBITDA for the first quarter of 2026 were RMB2.83 billion (US$410 million). Non-IFRS net profit was RMB2.33 billion (US$338 million) and non-IFRS net profit attributable to equity holders of the Company was RMB2.27 billion (US$330 million). Non-IFRS basic and diluted earnings per ADS were RMB1.48 (US$0.21) and RMB1.46 (US$0.21), respectively. Please refer to the section in this press release titled "Non-IFRS Financial Measures" for details.

As of March 31, 2026, the combined balance of the Company's cash, cash equivalents, term deposits and short-term investments amounted to RMB41.00 billion (US$5.94 billion), compared with RMB38.04 billion as of December 31, 2025. 

Declaration and Payment of 2025 Dividend

On March 17, 2026, the Company's board of directors declared a cash dividend of US$0.12 per ordinary share, or US$0.24 per ADS, for the year ended December 31, 2025, to holders of record of ordinary shares and ADSs as of the close of business on April 2, 2026. The payment for the cash dividend of US$370 million was made in April 2026.

Environmental, Social, and Governance ("ESG")

On April 20, 2026, we released our 2025 ESG Report, detailing our progress in empowering creators, promoting digital inclusion, and driving sustainability across our value chain. These initiatives have strengthened our ecosystem's resilience, leading to improved ESG ratings and broader recognition from our stakeholders.

Exchange Rate

This announcement contains translations of certain RMB amounts into U.S. dollars ("USD") at specified rates solely for the convenience of the reader. Unless otherwise stated, all translations from RMB to USD were made at the rate of RMB6.8980 to US$1.00, the noon buying rate in effect on March 31, 2026, in the H.10 statistical release of the Federal Reserve Board. The Company makes no representation that the RMB or USD amounts referred could be converted into USD or RMB, as the case may be, at any particular rate or at all. For analytical presentation, all percentages are calculated using the numbers presented in the financial statements contained in this earnings release.

Non-IFRS Financial Measures 

The Company uses non-IFRS financial measures for the period, including non-IFRS net profit, adjusted EBITDA(inc.SBC) and adjusted EBITDA, in evaluating its operating results and for financial and operational decision-making purposes. TME believes that non-IFRS financial measures help identify underlying trends in the Company's business that could otherwise be distorted by the effect of certain expenses that the Company includes in its profit for the period. TME believes that non-IFRS financial measures for the period provide useful information about its results of operations, enhances the overall understanding of its past performance and future prospects and allows for greater visibility with respect to key metrics used by its management in its financial and operational decision-making. 

Non-IFRS financial measures for the period should not be considered in isolation or construed as an alternative to operating profit, net profit for the period or any other measure of performance or as an indicator of its operating performance. Investors are encouraged to review non-IFRS financial measures for the period and the reconciliation to its most directly comparable IFRS measure. Non-IFRS financial measures for the period presented here may not be comparable to similarly titled measures presented by other companies. Other companies may calculate similarly titled measures differently, limiting their usefulness as comparative measures to the Company's data. TME encourages investors and others to review its financial information in its entirety and not rely on a single financial measure. 

Adjusted EBITDA(inc.SBC) for the period represents net profit for the period excluding income tax expense, finance cost, share of profit/loss of associates and joint ventures, other gains/losses, interest income, depreciation of property, plant and equipment and right-of-use assets, and amortization of intangible assets. 

Adjusted EBITDA for the period represents net profit for the period excluding income tax expense, finance cost, share of profit/loss of associates and joint ventures, other gains/losses, interest income, depreciation of property, plant and equipment and right-of-use assets, amortization of intangible assets, and share-based compensation expenses. 

Non-IFRS net profit for the period represents profit for the period excluding amortization of intangible and other assets arising from business acquisitions or combinations, share-based compensation expenses, net losses/gains from investments and related income tax effects.

Please see the "Unaudited Non-IFRS Financial Measures" included in this press release for a full reconciliation of adjusted EBITDA(inc.SBC), adjusted EBITDA and non-IFRS net profit for the period to its net profit for the period.

About Tencent Music Entertainment

Tencent Music Entertainment Group (NYSE: TME and HKEX: 1698) is the leading online music and audio entertainment platform in China, operating the country's highly popular and innovative music apps: QQ Music, Kugou Music, Kuwo Music and WeSing. TME's mission is to create endless possibilities with music and technology. TME's platform comprises online music, online audio, online karaoke, music-centric live streaming and online concert services, enabling music fans to discover, listen, sing, watch, perform and socialize around music. For more information, please visit ir.tencentmusic.com.

Safe Harbor Statement

This press release contains forward-looking statements. These statements are made under the "safe harbor" provisions of the U.S. Private Securities Litigation Reform Act of 1995. Statements that are not historical facts, including statements about the Company's beliefs and expectations, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties, and a number of factors could cause actual results to differ materially from those contained in any forward-looking statement. In some cases, forward-looking statements can be identified by words or phrases such as "may," "will," "expect," "anticipate," "target," "aim," "estimate," "intend," "plan," "believe," "potential," "continue," "is/are likely to" or other similar expressions. Further information regarding these and other risks, uncertainties or factors is included in the Company's filings with the SEC and the HKEX. All information provided in this press release is as of the date of this press release, and the Company does not undertake any duty to update such information, except as required under applicable law.

Investor Relations Contact 
Tencent Music Entertainment Group
[email protected]  
+86 (755) 8601-3388 ext. 885034

SÃO PAULO, May 12, 2026 /PRNewswire/ -- ZTE Corporation (0763.HK / 000063.SZ), a global leading provider of integrated information and communication technology solutions, successfully hosted its Broadband User Congress, themed "Monetize Your Intelligent Broadband". The event gathered over 300 executives from ISPs, operators, government, industry associations, and ecosystem partners across Latin America. Driven by network cost reduction, efficiency improvement and home service innovation, the congress presented comprehensive intelligent broadband monetization solutions for Latin America. These help operators and ISPs move beyond pipe-only models, boosting basic network ARPU, diversifying revenues and reshaping competitiveness.

Fang Hui, Senior Vice President of ZTE, stated: "With over 20 years of presence in Latin America, ZTE has delivered hundreds of landmark projects and served over 100 million users in Brazil. We will drive premium experiences through technological innovation, unlock growth potential through win-win partnerships, and empower industrial transformation with AI. Leveraging our full-stack 'Connectivity + Computing' capabilities, we are committed to building an open, intelligent digital ecosystem and co-creating new value with Latin American partners."

ZTE showcased innovative network operation concepts and upgraded portfolios, translating "Monetize Your Intelligent Broadband" into deployable and profitable practices.

For operator broadband network construction, ZTE is committed to building the best-in-class broadband network for every customer.

In access, ZTE's FTTx monetization solutions lower network deployment barriers via lightweight OLTs, adopt CEM+AI to enable precise quality analysis and targeted marketing, and expand into the B2B blue ocean market with AI all-optical campus and AI Interactive Flat Panel, balancing cost reduction, efficiency improvement and ARPU growth. The end-to-end intelligent ODN system ensures full-lifecycle network assurance.

In transport, ZTE launched a C+L full-band 1.6T OTN solution enhanced with AI. It delivers breakthroughs in single-wavelength rate, spectrum efficiency, and intelligent O&M, addressing scaling, cost reduction and agile service delivery. It also launched a single-slot 28.8 Tbps core router and high-performance 100GE/400GE aggregation routers, enabling operators to build next-generation IP networks that are ultra-broadband, green, secure, and intelligent, laying a foundation for broadband value upgrade.

In smart O&M, the AIOps platform significantly improves fault diagnosis efficiency. It reduces OPEX and drives evolution toward L4 autonomous networks.

For home broadband, ZTE leverages strong technology and continuous AI innovation to ensure optimal TCO.

In smart connectivity, AI Wi-Fi 7 serves as the core, leveraging advantages in specifications, coverage, control, hardware, software and supply chain to help operators optimize TCO and achieve precise selection.

In smart home value-added services, large-model capabilities empower AI O&M, AI cameras and AI Smart View, creating new home experiences integrating smart control, fitness, entertainment and security, shifting from basic connectivity to high-value services.

In smart operations, the SCP platform enables unified home device management with remote diagnostics, one-click optimization, stolen-device locking and targeted VAS marketing, reducing O&M costs, stabilizing revenue and building efficient systems for sustainable monetization.

ZTE empowers ISPs to increase revenue through lightweight deployment and converged efficiency.

Light PON enables fast, cost-effective network deployment, shortening time-to-market.

Light OTN features a 12.8T-in-2U high-density design with minimalist WebGUI management, supporting single-wavelength 1.6T, zero-touch deployment and plug-and-play, reducing costs and O&M complexity while ensuring optimal TCO.

Light IP Network provides end-to-end lightweight IP convergence from CPE to backbone, built on a unified open architecture, smooth product evolution and AI-powered minimalist O&M, enabling heterogeneous network integration and safeguarding ISP operations.

At the event, ZTE launched the new-generation TV 3.0 set-top box, marking a new phase in Brazil's digital TV upgrade. ZTE and MediaTek jointly introduced Wi-Fi 7 and 10G PON solutions for premium home and SMB scenarios, helping operators tap high-value users. Qualcomm and ZTE are collaborating on next-generation networking infrastructure for the AI Era, combining Qualcomm's AI-native Wi-Fi and FWA platforms with ZTE's access and networking leadership.

Lu Maoliang, President of ZTE Brazil, commented: "Brazil is a core strategic market for ZTE. With 25 years of localized operations in Latin America, we have served over 100 operators and ISPs, deployed more than 60,000 km of optical fiber, and reached over 30 million households. This congress precisely addresses local demands, delivering leading technologies and products while focusing on driving customers' sustainable commercial success."

MEDIA INQUIRIES:
ZTE Corporation
Communications
Email: [email protected]

巴西聖保羅2026年5月12日 /美通社/ -- 5月6日，中興通訊在巴西聖保羅成功舉辦第五屆「智慧寬帶 變現未來」寬帶用戶大會。從安第斯山麓的哥倫比亞，到北美樞紐墨西哥，再到南美第一大市場巴西，中興通訊持續探索拉美寬帶經營新路徑。本次大會匯聚巴西及拉美地區300餘家主流運營商、ISP、行業專家與生態夥伴，巴西本地政府及行業協會等諸多領袖亦應邀出席。大會以寬帶網絡降本增效、家庭業務創新為雙引擎，依托系列智能寬帶變現解決方案，精準適配拉美細分市場及場景需求，助力運營商與ISP突破傳統管道經營模式，拉升基礎網絡ARPU、拓寬增收路徑、重塑行業核心競爭力。

中興通訊高級副總裁方暉在開幕致辭中表示，公司深耕拉美二十餘年，落地數百個標桿通信項目，網絡服務覆蓋巴西超1億用戶，深度扎根區域數字基礎設施建設。面向未來，中興通訊將持續以技術創新打造極致網絡體驗，以生態共贏釋放產業增長動能，以AI賦能全產業鏈升級；憑借「連接+算力」全棧能力，構建開放共生的智能數字生態，攜手拉美合作夥伴共創產業全新價值。

大會現場，中興通訊面向運營商及ISP市場，展示全新網絡經營理念與創新產品解決方案，將「智慧寬帶 變現未來」戰略構想轉化為可落地、可盈利的商業實踐。

面向運營商寬帶網絡建設，中興通訊始終致力於為每一位客戶打造「最好的寬帶網絡」。

在光接入領域， FTTx變現方案通過輕量化OLT降低建網門檻、CEM+AI實現精細化質差分析與精準營銷、AI全光園區與AI智會屏等創新拓展To B藍海市場，兼顧成本效率與ARPU提升，持續挖掘網絡增量價值。端到端智能ODN系統則為全生命週期網絡提供有力保障。

在承載網領域， C+L全頻一體化1.6T OTN方案，融合AI技術，憑借單波速率升級、極致頻譜利用率與智能化運維能力，攻克光網擴容成本高、服務響應慢等行業難題。同時，單槽28.8Tbps核心路由器與高性能100GE/400GE接入匯聚路由器，疊加AI流量智能調優、AI安全防護、AI動態節能功能，助力運營商搭建超寬、綠色、安全、智能的新一代IP網絡。

在智能運維側，AIOps智能運維平台大幅提升故障診斷效率，顯著削減全網OPEX，助力運維體系向L4級高階自智網絡穩步演進。

面向家庭寬帶網絡建設，中興通訊憑借「硬核技術實力及持續的AI技術創新」，以質量保障為支點、智能管控為優勢、長期演進為方向，為客戶提供更優的TCO保障。

在智能連接領域，以AI Wi-Fi 7為核心，充分發揮規格、覆蓋、管控、軟硬件及供應鏈等多重優勢，助力運營商精準選型與TCO持續優化。結合定制化套餐策略，幫助運營商擺脫價格戰，構建差異化競爭力。

在智慧家庭增值業務方面，以大模型能力為基座，聚焦AI運維、AI攝像頭、AI中屏三大核心抓手，打造集智管智控、健身娛樂、隨心看家於一體的家庭新體驗，推動家庭業務從基礎連接向高價值服務升級。

在智能運營方面，SCP平台實現全類型家庭設備統一納管、遠程診斷運維、一鍵網絡優化、被盜設備鎖定及基於多樣化報表的增值業務定向營銷，全業務一站式捆綁，降低運維成本、穩定提升收益，助力運營商構建高效運營體系，實現可持續價值變現。

針對ISP市場，中興通訊以「輕量建網、融合提效」破局，賦能增收。

輕量化PON方案實現快速、高性價比網絡部署，顯著縮短上市時間，幫助ISP搶佔市場先機。

Light OTN方案採用12.8T@2U高集成度設計+WebGUI極簡管理，支持單波1.6T傳輸及「零部署、上電即開通」，顯著降低光網絡部署成本與運維複雜度。

Light IP Network打通從CPE到接入、匯聚、骨幹的端到端輕量化IP融合方案，以統一開放架構、平滑演進產品、極簡智能運維為三大支柱，助力ISP實現異構網絡融合與持續運營。

在上述場景化方案之外，本次大會還迎來了三大亮點合作的集中呈現：中興通訊推出新一代TV 3.0機頂盒，標誌著巴西數字電視升級邁入關鍵階段；中興通訊攜手聯發科推出面向高端家庭與中小商業場景的Wi-Fi 7與萬兆光網絡解決方案，助力運營商挖掘高價值用戶；高通與中興通訊攜手打造面向 AI 時代的新一代網絡基礎設施，整合了高通原生 AI Wi-Fi、固定無線接入（FWA）平台技術，以及中興通訊在接入與網絡解決方案領域的技術領先優勢。

中興通訊副總裁、巴西代表處總經理呂茂亮表示，巴西是公司全球核心戰略市場。深耕拉美25年，中興通訊累計服務超100家運營商與ISP，鋪設光纖超6萬公里，覆蓋超3000萬家庭用戶。他指出，本次大會正是對本地客戶需求的精準回應：不止輸出領先技術與產品，更聚焦助力客戶實現商業成功。

面向未來，中興通訊將持續以「智慧寬帶變現未來」為指引，深耕巴西及拉美市場，依托「連接+算力」全棧技術能力，攜手本地運營商與生態夥伴，推動智能寬帶從建網覆蓋走向價值經營，助力區域通信產業實現高質量、可持續增長，共繪巴西數字經濟發展新藍圖。

媒體垂詢：
中興通訊
傳播部
電子郵件：[email protected]  

SHENZHEN, China, May 12, 2026 /PRNewswire/ -- TCL, a leading global technology company, announced its inclusion in Forbes' 2025 list of the World's Top Companies for Women, recognizing its success in building an inclusive culture and championing women in the workplace.

To compile the list, Forbes partnered with market research firm Statista to survey approximately 120,000 women working for multinational corporations in more than 36 countries. Each company's score aggregates survey responses with a "public opinion score" that quantifies women's gender perceptions of different companies, as well as data on women in executive and board positions. The list ranks 400 corporations with a significant global presence across at least two continents.

In addition to career advancement, TCL offers family-friendly benefits such as mother and baby rooms, extended paid maternity leave and childbirth allowances, along with women's healthcare services including cancer screening and psychological counseling.

"Women's empowerment is a core component of TCL's globalization and sustainability strategy, linking our technological innovation with social development," said Wei Xue, Vice President & Chief of the ESG Office at TCL Technology Group Corporation, and Chairperson of TCL Charity Foundation. "Our inclusion on Forbes' list is a tribute to TCL's long-term commitment to empowering women in the workplace and supporting their career development. We are honored to be included and proud of our track record of creating opportunity for all people."

TCL operates in more than 160 countries and regions, engaging with local communities and respecting local cultural norms to empower women in the workplace. The company maintains its commitment to diversity and inclusion by assessing Environmental, Social and Governance indicators in its global subsidiaries and using this data to inform its employment policies.

TCL Extends Female Empowerment Mission Beyond the Workplace

Since 2018, TCL has partnered with FIBA, the world's governing body for basketball, to promote female participation in the sport. The company has supported numerous global events and will continue its involvement with the upcoming FIBA Women's World Cup in Germany in September and the 2027 FIBA World Cup in Qatar. 

Through the Huameng Foundation, a philanthropic initiative established by TCL's founders, the company funds female-focused programs that have enabled nearly 1,000 young women from underprivileged families to complete high school and tertiary studies. The Foundation uses technology to advance its charitable causes, supporting community development in China and elsewhere.

In addition, TCL's dynamic and long-running #TCLforHer campaign leverages technology, sports and education to empower young women and nurture their ambitions through a variety of community initiatives. The campaign shares stories of trailblazers who challenge assumptions and tear down boundaries, inspiring women everywhere to boldly defy stereotypes and fulfill their potential. 

#TCLforHer has received numerous international marketing honors for its storytelling prowess. In January 2025, it won a prestigious Silver Telly Award—a major prize in the global documentary and TV brand film sector—for its 2024 marketing campaign, which centers around two brand films produced by a predominantly female team. 

TCL's inclusion on the Forbes list of the World's Top Companies for Women marks an important milestone, affirming the company's leadership in female empowerment and commitment to breaking the glass ceiling for women worldwide.

About TCL

Founded in 1981, TCL—short for "The Creative Life"—embodies creativity in every aspect of life. As a leading technology brand, TCL is dedicated to delivering innovative solutions—including TVs, smartphones, audio products, smart home devices, display technologies, and clean energy—that enhance customer experiences through two independent entities—TCL Industries and TCL Technology.

With 47 R&D centers and 40 manufacturing bases globally, TCL operates in over 160 countries and regions, cementing its position as a globally competitive smart technology brand. To further inspire greatness, TCL has become an official Worldwide Olympic and Paralympic Partner in the Home Audiovisual Equipment and Home Appliances category.

Landmark collaboration leverages complementary capabilities to drive speed in early innovation and help advance medicines for patients worldwide

Agreements include 13 programs with the potential to address significant unmet patient needs and support long‑term growth

SHANGHAI and PRINCETON, N.J., May 12, 2026 /PRNewswire/ -- Hengrui Pharma ("Hengrui") (600276.SH; 01276.HK) and Bristol Myers Squibb ("BMS") today announced the companies have entered into global strategic collaboration and license agreements to advance a portfolio of 13 early stage programs in oncology, hematology and immunology, with the goal of accelerating discovery and development of innovative medicines for the benefit of patients worldwide.

The agreements include four oncology/hematology assets from Hengrui, four immunology assets from BMS, and five innovative assets to be jointly discovered and developed by both companies, leveraging Hengrui's discovery engine and platform technologies across several innovative modalities. Hengrui has the option to co-develop select assets and the potential to conduct certain commercialization activities globally with BMS.

Under the collaboration, BMS obtains exclusive worldwide rights to the Hengrui‑originated assets outside Chinese mainland, Hong Kong SAR, and Macau SAR (the "Hengrui Territory"), while Hengrui obtains exclusive rights to the BMS‑originated assets within the Hengrui Territory, with BMS retaining rights for the rest of the world. Hengrui will be fully responsible for early clinical development to accelerate clinical proof of concept for these programs.

Aligned with the collaborative innovation strategies of both BMS and Hengrui, these agreements reflect the companies' continued focus on advancing innovative science through partnership in areas of significant unmet medical need. The collaboration brings together BMS's differentiated research and discovery strengths, global clinical development capabilities, regulatory expertise, and commercial scale with Hengrui Pharma's discovery engine, platform technologies, and efficient early-stage development expertise, enabling the advancement of a broad portfolio of high-value programs.

"This broad strategic collaboration reflects a highly synergistic collaboration between two global innovators with complementary strengths. By leveraging Hengrui's growing R&D capabilities and proven efficiency in discovering and advancing innovative therapies, we are poised to advance the best of both pipelines," said Frank Jiang, MD, PhD, Executive Vice President and Chief Strategy Officer of Hengrui Pharma. "It also reflects Hengrui's continued commitment to strengthen our global presence. Together, we aim to deliver meaningful benefits to patients worldwide."

"This strategic collaboration reflects our commitment to advancing innovative science while maintaining a disciplined approach to portfolio management," said Robert Plenge, MD, PhD, Executive Vice President and Chief Research Officer, Bristol Myers Squibb. "By leveraging complementary capabilities across geographies, we aim to accelerate early clinical learning and make informed decisions that support driving top tier growth in the next decade and, ultimately, our mission to deliver medicines that help patients prevail over serious diseases."

Under the terms of the agreement, BMS will pay Hengrui up to $950 million, including a $600 million upfront payment, a $175 million first anniversary payment, and a second contingent anniversary payment of $175 million in 2028. The potential total value of the agreement is up to approximately $15.2 billion, including the exercise of available options for the joint discovery programs and the achievement of applicable development, regulatory, and commercial milestones for all programs. In addition, Hengrui is eligible to receive tiered royalties on net sales of products commercialized outside the Hengrui Territory.

The transaction is subject to review under the Hart‑Scott‑Rodino Antitrust Improvements Act and other customary closing conditions. The parties expect that the agreement will close in the third quarter of 2026.

About Bristol Myers Squibb: Transforming Patients' Lives Through Science
At Bristol Myers Squibb, our mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. We are pursuing bold science to define what's possible for the future of medicine and the patients we serve. For more information, visit us at BMS.com and follow us on LinkedIn, X, YouTube, Facebook and Instagram.

Bristol Myers Squibb Cautionary Statement Regarding Forward-Looking Statements
This press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 regarding, among other things, the research, development and commercialization of pharmaceutical products and the strategic collaboration and license agreements with Hengrui Pharma.  All statements that are not statements of historical facts are, or may be deemed to be, forward-looking statements. Such forward-looking statements are based on current expectations and projections about our future financial results, goals, plans and objectives and involve inherent risks, assumptions and uncertainties, including internal or external factors that could delay, divert or change any of them in the next several years, that are difficult to predict, may be beyond our control and could cause our actual future financial results, goals, plans and objectives to differ materially from those expressed in, or implied by, the statements. These risks, assumptions, uncertainties and other factors include, among others, that the expected benefits of, and opportunities related to, the agreement may not be realized by Bristol Myers Squibb or may take longer to realize than anticipated, that Bristol Myers Squibb may fail to discover and develop any commercially successful product candidates through the agreement, and that assets or product candidates may not achieve their primary study endpoints or receive regulatory approval for the indications described in this release in the currently anticipated timeline or at all and, if approved, whether such product candidate treatment or combination treatment for such indications described in this release will be commercially successful.

No forward-looking statement can be guaranteed. Forward-looking statements in this press release should be evaluated together with the many risks and uncertainties that affect Bristol Myers Squibb's business and market, particularly those identified in the cautionary statement and risk factors discussion in Bristol Myers Squibb's Annual Report on Form 10-K for the year ended December 31, 2025, as updated by our subsequent Quarterly Reports on Form 10-Q, Current Reports on Form 8-K and other filings with the Securities and Exchange Commission. The forward-looking statements included in this document are made only as of the date of this document and except as otherwise required by applicable law, Bristol Myers Squibb undertakes no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events, changed circumstances or otherwise.

About Hengrui Pharma: Innovation to Benefit Patients Worldwide
Hengrui Pharma is an innovative, global pharmaceutical company dedicated to the research, development and commercialization of high-quality medicines to address unmet clinical needs. Its therapeutic areas of focus include oncology, metabolic and cardiovascular diseases, immunological and respiratory diseases, and neuroscience. Driven by a patient-focused philosophy since its founding in 1970, Hengrui Pharma remains committed to advancing human health by striving to conquer diseases, improve health, and extend lives through the power of science and technology. For more information, visit us at Hengrui.com and follow us on LinkedIn.

Hengrui Pharma Cautionary Statement Regarding Forward-Looking Statements
This press release contains statements that reflect Hengrui Pharma's beliefs or expectations about the future or future events as of the respective dates indicated therein ("forward-looking statements"). These forward-looking statements are based on a number of assumptions about Hengrui Pharma's operations, its future development plans, market (financial and otherwise) conditions and growth prospects, and are subject to significant risks, uncertainties and other factors beyond Hengrui Pharma's control, and accordingly, actual results may differ materially from those contemplated by these forward-looking statements. No reliance should be placed on such statements, which reflect the view of the management of Hengrui Pharma as at the date of this press release. Hengrui Pharma does not undertake any obligation to update these forward-looking statements for events/or circumstances that occur subsequent to such dates.

深圳2026年5月12日 /美通社/ -- 近日，全球領先的AI+機器人藥物研發平台晶泰科技（2228.HK）聯合長江生命科技（CK Life Sciences）全資子公司順譜醫藥科技（Sequencio Therapeutics），在美國癌症研究協會（AACR）年會上正式發佈了雙方在AI癌症疫苗平台研發中取得的最新臨床前成果。依托晶泰科技自主研發的PepiX™ AI多肽藥物開發平台，研究團隊針對極具挑戰的廣譜抗癌靶點p53成功優化出新抗原肽段，在親和力、免疫原性、應答持久度方面均展現出優越的實驗數據，取得了該領域具有突破性的進展，為癌症疫苗的後續開發奠定了堅實基礎。這一進展不僅標誌著晶泰科技的AI多肽藥物研發平台在攻堅「難成藥」靶點上取得了實質性成果，更意味著雙方共同開發的AI癌症疫苗平台正穩步跨越早期發現階段。雙方將繼續緊密合作，加速平台成果轉化為具備高臨床潛力的前沿管線。

攻克「抑癌之王」：AI破解p53靶點的長期難題

在腫瘤免疫治療領域，p53作為人類腫瘤中突變頻率最高的抑癌基因，相關突變存在於全球近半數的癌症患者中，覆蓋肺癌、乳腺癌、結直腸癌等多個高發癌種，孕育著巨大的未滿足臨床需求與百億級市場藍海。多肽疫苗憑借其高靶向性、安全性與成本優勢，有望精準引導免疫系統識別並摧毀腫瘤細胞，最大限度減少對健康組織的損傷，並激發持久的T細胞免疫記憶，從根本上防範腫瘤復發。然而，p53新抗原長期以來因免疫原性偏弱、且人類白細胞抗原（HLA）結合譜系狹窄，成藥難度極大，一直被視為傳統研發手段難以摘取的「高懸果實」。

面對這一挑戰，晶泰科技憑借PepiX™平台千萬量級的高質量數據，成功構建了行業領先的深度學習預測模型，並應用於p53新抗原肽的快速預測、序列優化及免疫原性提升。平台顯著提高了對主流MHC-I等位基因的多肽呈遞預測成功率，且AI設計的抗原表位在小鼠模型中展現出強效的T細胞激活能力，經篩選活化的T細胞對腫瘤細胞的殺傷效率超過50%。實驗數據證實，經PepiX™優化改造的肽段能夠與HLA多個主流亞型形成高親和力的穩定結合，並在人源化HLA模型中顯著增強了免疫原性。臨床前細胞免疫原性篩查進一步表明，相較於原始母本肽段，AI設計的修飾肽段可誘導產生更為優異且持久的CD8+ T細胞免疫應答。這些優化後的新表位展現出更出色的交叉反應性與抗腫瘤潛力，為p53驅動型癌症免疫治療的臨床開發奠定了堅實的基礎。

共享百億藍海：AI癌症疫苗平台的商業化加速

隨著生物技術的進步，腫瘤疫苗正處於快速發展的關鍵節點。根據Grand View Research預測，全球癌症疫苗市場將從2025年的99億美元增長至2033年的233億美元，年複合增長率達11.3%。瞄準這一藍海，晶泰科技與長江生命科技於2022年攜手啟動AI癌症疫苗平台合作。2026 年 3 月，長江生命科技宣佈成立公司全資附屬公司順譜醫藥，專注推動旗下治療性癌症疫苗組合的發展。此次AACR發佈的積極數據，充分驗證了該AI癌症疫苗平台的行業領先性。未來，順譜醫藥將與晶泰科技繼續緊密合作，全面推進臨床轉化與商業化。這種「前沿AI算法+頂尖產業資源」深度綁定的創新模式，不僅極大地提升了研發成功率與效率，更樹立了深港兩地生物醫藥產業協同發展的新標桿，加速將科學突破轉化為切實的產業回報。

PepiX™：打造多肽藥物創新的底層基礎設施

多肽藥物兼具小分子藥物的組織穿透性與大分子生物藥的高靶向性，市場潛力巨大，是晶泰科技繼小分子與抗體藥物之後，又一實現前沿技術產業化落地與商業驗證的核心AI研發領域。針對多肽半衰期短、細胞穿透性差等傳統研發痛點，晶泰科技自主研發了一體化多肽開發平台PepiX™。該平台整合了精準AI分子設計、自動化合成與高通量濕實驗篩選三大核心能力，形成「干實驗設計+濕實驗驗證」的高效閉環。PepiX™不僅能顯著縮短研發週期，更能快速篩選出pM級高親和力與高穩定性的分子。

目前，PepiX™已成功賦能數十個複雜多肽研發項目，靶點涵蓋酶、激素、膜蛋白及複雜無序蛋白。其核心的AI驅動多肽分子生成技術、「一珠一物」化學組合庫篩選技術及萬億規模的mRNA展示肽庫篩選技術均已獲得國內外客戶的高度認可，構建起高技術壁壘的一體化多肽研發平台。

在RDC核藥領域，公司聯合景嘉航開啟「AI+核藥」新一代多肽載體開發；在代謝疾病領域，攜手甘李藥業加速創新藥發現，實現從技術研發到臨床轉化的全鏈條協作；在口服多肽領域與興微達深度合作，致力於改變自免、代謝領域多肽藥物主要依賴注射的臨床現狀。通過在穿越血腦屏障（BBB）、難成藥IDP靶點等前沿領域的持續深耕，晶泰科技正以持續獲得驗證的交付能力，將PepiX™平台打造為驅動全球新藥創新的底層基礎設施。未來，公司將繼續拓寬多肽成藥的邊界，以前沿科技加速普適性療法的落地，持續為產業創造科學價值與商業回報。

關於順譜醫藥科技有限公司

順譜醫藥科技有限公司（Sequencio Therapeutics Company Limited，「Sequencio」）為長江生命科技集團有限公司全資附屬公司，專注研發能激活患者自身免疫系統對抗癌細胞的治療性疫苗，旨在維持良好安全性前提下，實現持久而穩定的病情緩解，從而應對現有標準療法的關鍵局限。Sequencio 肩負長遠願景——重塑癌症治療模式，從引導短暫性腫瘤縮小，邁向透過免疫系統達致長期可控的緩解。

關於晶泰科技

晶泰科技（「XtalPi Holdings Limited」，股份簡稱：晶泰控股，XTALPI，股票代碼：2228.HK）由三位麻省理工學院的物理學家於 2015 年創立，是一個基於量子物理、以人工智能賦能和機器人驅動的創新型研發平台。公司採用基於量子物理的第一性原理計算、人工智能、高性能雲計算以及可擴展及標準化的機器人自動化相結合的方式，為製藥及材料科學（包括農業技術、能源及新型化學品以及化妝品）等產業的全球和國內公司提供藥物及材料科學研發解決方案及服務。

SHENZHEN, China, May 11, 2026 /PRNewswire/ -- TCL, a leading global technology company, announced its inclusion in Forbes' 2025 list of the World's Top Companies for Women, recognizing its success in building an inclusive culture and championing women in the workplace.

To compile the list, Forbes partnered with market research firm Statista to survey approximately 120,000 women working for multinational corporations in more than 36 countries. Each company's score aggregates survey responses with a "public opinion score" that quantifies women's gender perceptions of different companies, as well as data on women in executive and board positions. The list ranks 400 corporations with a significant global presence across at least two continents.

In addition to career advancement, TCL offers family-friendly benefits such as mother and baby rooms, extended paid maternity leave and childbirth allowances, along with women's healthcare services including cancer screening and psychological counseling.

"Women's empowerment is a core component of TCL's globalization and sustainability strategy, linking our technological innovation with social development," said Wei Xue, Vice President & Chief of the ESG Office at TCL Technology Group Corporation, and Chairperson of TCL Charity Foundation. "Our inclusion on Forbes' list is a tribute to TCL's long-term commitment to empowering women in the workplace and supporting their career development. We are honored to be included and proud of our track record creating opportunity for all people."

TCL operates in more than 160 countries and regions, engaging with local communities and respecting local cultural norms to empower women in the workplace. The company maintains its commitment to diversity and inclusion by assessing Environmental, Social and Governance indicators in its global subsidiaries and using this data to inform its employment policies.

TCL Extends Female Empowerment Mission Beyond the Workplace

Since 2018, TCL has partnered with FIBA, the world's governing body for basketball, to promote female participation in the sport. The company has supported numerous global events and will continue its involvement with the upcoming FIBA Women's World Cup in Germany in September and the 2027 FIBA World Cup in Qatar. 

Through the Huameng Foundation, a philanthropic initiative established by TCL's founders, the company funds female-focused programs that have enabled nearly 1,000 young women from underprivileged families to complete high school and tertiary studies. The Foundation uses technology to advance its charitable causes, supporting community development in China and elsewhere.

In addition, TCL's dynamic and long-running #TCLforHer campaign leverages technology, sports and education to empower young women and nurture their ambitions through a variety of community initiatives. The campaign shares stories of trailblazers who challenge assumptions and tear down boundaries, inspiring women everywhere to boldly defy stereotypes and fulfill their potential. 

#TCLforHer has received numerous international marketing honors for its storytelling prowess. In January 2025, it won a prestigious Silver Telly Award—a major prize in the global documentary and TV brand film sector—for its 2024 marketing campaign, which centers around two brand films produced by a predominantly female team. 

TCL's inclusion on the Forbes list of the World's Top Companies for Women marks an important milestone, affirming the company's leadership in female empowerment and commitment to breaking the glass ceiling for women worldwide.

About TCL

Founded in 1981, TCL—short for "The Creative Life"—embodies creativity in every aspect of life. As a leading technology brand, TCL is dedicated to delivering innovative solutions—including TVs, smartphones, audio products, smart home devices, display technologies, and clean energy—that enhance customer experiences through two independent entities—TCL Industries and TCL Technology.

With 47 R&D centers and 40 manufacturing bases globally, TCL operates in over 160 countries and regions, cementing its position as a globally competitive smart technology brand. To further inspire greatness, TCL has become an official Worldwide Olympic and Paralympic Partner in the Home Audiovisual Equipment and Home Appliances category.

Taiwan bourse last quoted at 41,917 this morning (11th), up 313 points or about 0.75%. Global chip foundry leader TSMC (2330.TT) bucked the trend, sagging 1.5% to TWD2,255.

Apple Inc. (AAPL.US) and Intel Corporation (INTC.US) reached a preliminary agreement under which Intel will manufacture certain chips used to power Apple devices, the Wall Street Journal cited informed sources over the weekend as saying.

The two companies reportedly engaged in intensive negotiations for more than a year and finalized a formal agreement in recent months.

Major Asia-Pacific chip stocks thrived broadly this morning. SMIC (00981.HK) and HUA HONG SEMI (01347.HK) each spiked about 5%. In South Korea, Samsung Electronics (005930.KS) and SK Hynix (000660.KS) surged 5.7% and 11.2%, respectively, both notching record highs. In Japan, Kioxia (285A.JP) rallied 7.6% to a new high. MediaTek (2454.TW) in Taiwan also jumped up 8.8% to a record high.
~

AASTOCKS Financial News
Website: www.aastocks.com